Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
|---|---|---|---|---|---|
| SH2-H5248 | Human | Human SHP-2 Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| JAB-3312 | JAB-3312 | Phase 3 Clinical | Jacobio Pharmaceuticals Co Ltd | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung | Details |
| JAB-3068 | JAB-3068 | Phase 2 Clinical | Jacobio Pharmaceuticals Co Ltd, Abbvie Inc | Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Carcinoma, Adenoid Cystic; Esophageal Squamous Cell Carcinoma; Lymphoma; Carcinoma, Non-Small-Cell Lung | Details |
| Vociprotafib | RMC-4630; SAR-442720 | Phase 2 Clinical | Sanofi, Revolution Medicines Inc | Solid tumours; Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
| TNO-155 | TNO-155 | Phase 2 Clinical | Novartis Pharma Ag | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Small Cell Lung Carcinoma; Neoplasms; Kidney Diseases; Gastrointestinal Stromal Tumors; Colorectal Neoplasms; Hepatic Insufficiency; Esophageal Squamous Cell Carcinoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma | Details |
| GH-21 | GH-21; HBI-2376 | Phase 2 Clinical | Suzhou GenHouse pharmaceutical Co Ltd | Solid tumours; Head and Neck Neoplasms; Pancreatic Neoplasms; Colonic Neoplasms; Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| BR-790 | BR-790 | Phase 2 Clinical | Jiangxi Qingfeng Pharmaceutical Industry Co Ltd | Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| SHP2 inhibitor (Navire Pharma) | IACS-15509; BBP-398; IACS-13909; BMS-986466 | Phase 2 Clinical | Bridgebio Pharma Inc, The University Of Texas MD Anderson Cancer Center | Solid tumours; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
| RLY-1971 | RG-6433; RLY-1971; GDC-1971; RO-7517834 | Phase 1 Clinical | Relay Therapeutics Inc | Solid tumours; Colorectal Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung | Details |
| RG-001 | RG001; RG-001 | Phase 1 Clinical | Shanghai Lingji Biological Technology Co Ltd | Neoplasms | Details |
| HMPL-415S1 | HMPL-415S1 | Phase 1 Clinical | Hutchison Medipharma Ltd | Solid tumours | Details |
| BPI-442096 | Phase 1 Clinical | Betta Pharmaceuticals Co Ltd | Solid tumours; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung | Details | |
| ET-0038 | ET-0038 | Phase 1 Clinical | Solid tumours | Details | |
| PF-07284892 | ARRY-558; PF-07284892 | Phase 1 Clinical | Pfizer Inc | Solid tumours | Details |
| ICP-189 | ICP-189 | Phase 1 Clinical | InnoCare Pharma Ltd | Solid tumours; Carcinoma, Non-Small-Cell Lung | Details |
| ERAS-601 | ERAS-601 | Phase 1 Clinical | Erasca Inc | Solid tumours; Leukemia, Myeloid, Acute | Details |
| SH-3809 | SH3809 | Phase 1 Clinical | Nanjing Sanhome Pharmaceutical Co Ltd | Solid tumours | Details |
| JAB-3312 | JAB-3312 | Phase 3 Clinical | Jacobio Pharmaceuticals Co Ltd | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung | Details |
| JAB-3068 | JAB-3068 | Phase 2 Clinical | Jacobio Pharmaceuticals Co Ltd, Abbvie Inc | Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Carcinoma, Adenoid Cystic; Esophageal Squamous Cell Carcinoma; Lymphoma; Carcinoma, Non-Small-Cell Lung | Details |
| Vociprotafib | RMC-4630; SAR-442720 | Phase 2 Clinical | Sanofi, Revolution Medicines Inc | Solid tumours; Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
| TNO-155 | TNO-155 | Phase 2 Clinical | Novartis Pharma Ag | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Small Cell Lung Carcinoma; Neoplasms; Kidney Diseases; Gastrointestinal Stromal Tumors; Colorectal Neoplasms; Hepatic Insufficiency; Esophageal Squamous Cell Carcinoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma | Details |
| GH-21 | GH-21; HBI-2376 | Phase 2 Clinical | Suzhou GenHouse pharmaceutical Co Ltd | Solid tumours; Head and Neck Neoplasms; Pancreatic Neoplasms; Colonic Neoplasms; Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| BR-790 | BR-790 | Phase 2 Clinical | Jiangxi Qingfeng Pharmaceutical Industry Co Ltd | Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| SHP2 inhibitor (Navire Pharma) | IACS-15509; BBP-398; IACS-13909; BMS-986466 | Phase 2 Clinical | Bridgebio Pharma Inc, The University Of Texas MD Anderson Cancer Center | Solid tumours; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
| RLY-1971 | RG-6433; RLY-1971; GDC-1971; RO-7517834 | Phase 1 Clinical | Relay Therapeutics Inc | Solid tumours; Colorectal Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung | Details |
| RG-001 | RG001; RG-001 | Phase 1 Clinical | Shanghai Lingji Biological Technology Co Ltd | Neoplasms | Details |
| HMPL-415S1 | HMPL-415S1 | Phase 1 Clinical | Hutchison Medipharma Ltd | Solid tumours | Details |
| BPI-442096 | Phase 1 Clinical | Betta Pharmaceuticals Co Ltd | Solid tumours; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung | Details | |
| ET-0038 | ET-0038 | Phase 1 Clinical | Solid tumours | Details | |
| PF-07284892 | ARRY-558; PF-07284892 | Phase 1 Clinical | Pfizer Inc | Solid tumours | Details |
| ICP-189 | ICP-189 | Phase 1 Clinical | InnoCare Pharma Ltd | Solid tumours; Carcinoma, Non-Small-Cell Lung | Details |
| ERAS-601 | ERAS-601 | Phase 1 Clinical | Erasca Inc | Solid tumours; Leukemia, Myeloid, Acute | Details |
| SH-3809 | SH3809 | Phase 1 Clinical | Nanjing Sanhome Pharmaceutical Co Ltd | Solid tumours | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
